TY - JOUR
T1 - The effect of a benzotriazinium salt on in vitro and in vivo arrhythmias in guinea pigs and mice
AU - Scott, N C
AU - French, A M
PY - 1980
Y1 - 1980
N2 - In guinea pig Langendorff hearts, a benzotriazinium derivative, 2-n-propyl-4-p-tolylamino-1,2,3-benzotriazinium iodide (TnPBI), increased the ventricular refractory period, increased the ventricular fibrillation threshold to electrical stimulation and converted persistent ventricular fibrillation to sinus rhythm. TnPBI also converted aconitine-induced tachyarrhythmias to sinus rhythm in the same preparation. In mice pretreated with TnPBI, both acutely and chronically, the amount of intravenous aconitine necessary to produce cardiac arrhythmias was increased. In guinea pigs anesthetized with halothane, TnPBI converted adrenaline-induced arrhythmias to sinus rhythm.
AB - In guinea pig Langendorff hearts, a benzotriazinium derivative, 2-n-propyl-4-p-tolylamino-1,2,3-benzotriazinium iodide (TnPBI), increased the ventricular refractory period, increased the ventricular fibrillation threshold to electrical stimulation and converted persistent ventricular fibrillation to sinus rhythm. TnPBI also converted aconitine-induced tachyarrhythmias to sinus rhythm in the same preparation. In mice pretreated with TnPBI, both acutely and chronically, the amount of intravenous aconitine necessary to produce cardiac arrhythmias was increased. In guinea pigs anesthetized with halothane, TnPBI converted adrenaline-induced arrhythmias to sinus rhythm.
UR - http://www.scopus.com/inward/record.url?scp=0019136211&partnerID=8YFLogxK
M3 - Article
SN - 0003-9780
VL - 248
SP - 154
EP - 165
JO - Archives Internationales de Pharmacodynamie et de Thérapie
JF - Archives Internationales de Pharmacodynamie et de Thérapie
IS - 1
ER -